Mia's Feed
Medical News & Research

Genomic Analysis Shows Triple-Negative Breast Cancer in African American Women Is Not Linked to Ancestry

Genomic Analysis Shows Triple-Negative Breast Cancer in African American Women Is Not Linked to Ancestry

Share this article

Comprehensive genomic research reveals that triple-negative breast cancer in African American women is not linked to ancestry, highlighting common biological pathways and the roles of aging and obesity.

2 min read

Recent genomic research focusing on triple-negative breast cancer (TNBC), a particularly aggressive subtype of breast cancer, has provided new insights into its development in African American women. Historically, African American women have experienced higher incidence rates of TNBC, but whether this was due to genetic differences or social and environmental factors remained unclear.

A comprehensive study led by researchers at Roswell Park Comprehensive Cancer Center involved analyzing the genetic mutations of 462 African American women diagnosed with TNBC. Using whole-exome and RNA sequencing, the study generated the largest and most detailed mutational profile of this population. Findings revealed that the genetic mutation patterns in African American women with TNBC closely resemble those of Asian American and non-Hispanic white women. Importantly, there was no evidence linking the disease to African ancestry, challenging previously held assumptions.

A notable discovery was the near-universal presence of TP53 gene mutations among the African American TNBC patients, which was more prevalent than earlier believed. This suggests common biological pathways may be involved across different racial backgrounds, nullifying the idea that TNBC’s aggressive nature is solely driven by race-associated genetics.

The study also identified two primary pathways involved in the disease’s development. One pathway, more common among younger women, involves genetic predisposition and impaired DNA damage repair mechanisms. The other pathway, observed more frequently in older women, relates to aging processes and the impacts of obesity.

Dr. Yao emphasized that these findings indicate that biological differences at the level of somatic mutations are minimal across races. Instead, factors like aging and obesity might play significant roles in the development of TNBC, shifting focus away from race-based genetic explanations.

This study was made possible through collaboration among multiple institutions, including contributions from bioinformatics teams and large cohort studies such as the Women’s Circle of Health Study, the Black Women’s Health Study, and the Southern Community Cohort Study. The research highlights the importance of inclusive genomic studies and provides a pathway for more targeted approaches to treatment and prevention.

For more details, see the full study: Song Yao et al, "Mutational Landscape of Triple-Negative Breast Cancer in African American Women," published in Nature Genetics (2025).

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Promising Results for Ifinatamab Deruxtecan in Treating Extensive-Stage Small Cell Lung Cancer

Clinical trials highlight the promising efficacy and safety of ifinatamab deruxtecan in treating extensive-stage small cell lung cancer, offering new hope for patients with limited options.

Targeting FGFR1 as a Promising Therapeutic Strategy Against Cardiac Fibrosis

A multi-scale analysis uncovers FGFR1 inhibition as an effective approach to reduce cardiac fibrosis and improve heart function, offering new hope for treating dilated cardiomyopathy and heart failure.

AI Innovation Enables Detection of Fatty Liver Disease via Chest X-Rays

Innovative AI model analyzes routine chest X-rays to detect fatty liver disease, offering a cost-effective and accessible diagnostic method that could transform early screening strategies.

Autoantibodies in Patients Could Unlock New Strategies to Enhance Cancer Immunotherapy

Emerging research reveals that autoantibodies naturally produced by patients may enhance responses to cancer immunotherapy, offering new pathways to more effective personalized treatments.